Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Human efficacious dose and dosage schedule of spr720 2022-10-26 2023-5-04
Compounds 2022-8-23 2023-1-12
Novel oral dosage forms of tebipenem pivoxil for immediate and controlled … 2022-6-01 2022-8-09
High dosage tebipenem pivoxil tablet formulation 2021-11-12 2022-5-12
Compounds 2021-11-05 2022-9-01
Tebipenem pivoxil crystalline forms, compositions including the same, methods … 2021-5-24 2023-1-25
Polymyxin derivatives and their use in combination therapy together with … 2021-1-25 2021-7-22
Novel tebipenem pivoxil immediate and modified release oral dosage forms 2017-12-15 2022-1-06
Combination therapy to treat mycobacterium diseases 2017-1-19 2018-4-10 2018-4-10
Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors 2016-1-06 2016-7-14
Compounds derived from polymyxin 2015-11-26 2023-8-29 2023-8-29
Compounds 2015-11-26 2020-2-06 2020-2-06
Carbonyl linked bicyclic heteroaryl n-benzimidazoles and analogs as antibiotic … 2015-9-11 2016-3-17
Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors 2015-7-10 2016-1-14
POLYMYXIN DERIVATIVE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS INCLUDING SAID … 2015-3-11 2023-7-04
Polymyxin derivatives and their use in combination therapy together with … 2014-5-21 2022-9-12
Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H … 2013-7-18 2015-4-28 2015-4-28
Gyrase and topoisomerase IV inhibitors 2013-6-03 2015-3-03 2015-3-03
Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1- … 2013-6-03 2013-10-10
Process of making gyrase and topoisomerase inhibitors 2013-5-28 2013-10-03
Compounds 2012-11-16 2016-1-12 2016-1-12
Phosphate esters of gyrase and topoisomerase inhibitors 2012-6-20 2015-9-08 2015-9-08
Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl} … 2012-1-13 2016-2-02
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl) … 2012-1-13 2013-7-09 2013-7-09
Pyrimidine gyrase and topoisomerase iv inhibitors 2012-1-13 2016-2-02
Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1- … 2012-1-13 2016-2-02
Composes derives de la polymyxine 2015-11-26 2023-8-29 2023-8-29
Compostos derivados de polimixina, composições farmacêuticas compreendedo os … 2015-3-11 2023-7-04